Russell Micheal Hagan

Title: **Russell Micheal Hagan: Innovator in Medical Applications**

Introduction

Russell Micheal Hagan, based in Ware, GB, is an accomplished inventor recognized for his contributions to the field of medical science. He holds a patent for a groundbreaking innovation that focuses on the medical use of tachykinin antagonists.

Latest Patents

Hagan's notable patent involves the use of tachykinin antagonists, particularly substance P antagonists and other neurokinin antagonists, in treating emesis. This invention details not only the medical application of these antagonists but also introduces novel compounds of formula (I) and outlines the processes for their preparation, along with pharmaceutical compositions that incorporate these innovations.

Career Highlights

Russell Micheal Hagan is associated with Glaxo Group Limited, a leading company in pharmaceutical research and development. His work at Glaxo contributes significantly to the advancement of medical therapies aimed at improving patient outcomes in various conditions associated with nausea and vomiting.

Collaborations

During his career, Hagan has collaborated with fellow innovator Keith Thomas Bunce, working together to explore and develop new avenues in medical treatments, particularly those leveraging the properties of tachykinin antagonists.

Conclusion

Russell Micheal Hagan exemplifies the spirit of innovation within the pharmaceutical industry. His patent on tachykinin antagonists showcases his commitment to advancing medical science and improving therapeutic options for patients suffering from emesis. As he continues his work at Glaxo Group Limited, the potential for further breakthroughs remains promising.